Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 21.58%10.32B | ---- | 10.47%8.49B | ---- | -23.31%7.68B | ---- | 44.76%10.02B | ---- | 7.30%6.92B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 78.65%-8.39M | ---- | 34.40%-39.29M | ---- | -144.79%-59.9M | ---- | -9.89%-24.47M | ---- | 71.17%-22.27M |
| Interest expense - adjustment | ---- | -0.15%3.47B | ---- | -0.78%3.48B | ---- | 1.97%3.5B | ---- | 15.49%3.43B | ---- | -8.13%2.97B |
| Dividend (income)- adjustment | ---- | -32.87%-15.83M | ---- | 3.28%-11.91M | ---- | 88.42%-12.32M | ---- | 25.49%-106.39M | ---- | -141.88%-142.8M |
| Attributable subsidiary (profit) loss | ---- | -885.46%-271.04M | ---- | -106.56%-27.5M | ---- | -27.30%419.37M | ---- | 1,029.33%576.86M | ---- | 399.17%51.08M |
| Impairment and provisions: | ---- | -49.41%1.12B | ---- | 8.19%2.21B | ---- | 353.83%2.04B | ---- | --450.61M | ---- | ---- |
| -Impairment of property, plant and equipment (reversal) | ---- | 145.24%10.15M | ---- | -101.10%-22.44M | ---- | 697.98%2.04B | ---- | --256.23M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | 191.31%3.22M | ---- | -86.35%1.11M | ---- | --8.09M | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 13.12%85.5M | ---- | --75.58M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | -52.72%1.02B | ---- | 27,875.65%2.16B | ---- | -104.00%-7.77M | ---- | --194.38M | ---- | ---- |
| Revaluation surplus: | ---- | -100.31%-158K | ---- | 1,336.88%51.27M | ---- | 101.23%3.57M | ---- | -351.20%-289.58M | ---- | 93.17%115.28M |
| -Derivative financial instruments fair value (increase) | ---- | -1,041.32%-25.43M | ---- | 102.58%2.7M | ---- | -12.77%-104.52M | ---- | -180.40%-92.69M | ---- | 148.15%115.28M |
| -Other fair value changes | ---- | -47.97%25.27M | ---- | -55.07%48.57M | ---- | 154.90%108.09M | ---- | ---196.89M | ---- | ---- |
| Asset sale loss (gain): | ---- | -2,341.04%-640.85M | ---- | 1,751.04%28.6M | ---- | 67.34%-1.73M | ---- | 98.69%-5.3M | ---- | ---405.45M |
| -Loss (gain) from sale of subsidiary company | ---- | -2,341.04%-640.85M | ---- | --28.6M | ---- | ---- | ---- | ---- | ---- | --66.78M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | 67.34%-1.73M | ---- | 98.88%-5.3M | ---- | ---472.23M |
| Depreciation and amortization: | ---- | 7.58%11.75B | ---- | 6.43%10.92B | ---- | 13.81%10.26B | ---- | 16.56%9.02B | ---- | 1.33%7.73B |
| -Depreciation | ---- | 8.75%11.22B | ---- | 6.94%10.32B | ---- | 13.53%9.65B | ---- | 17.92%8.5B | ---- | 1.34%7.21B |
| -Other depreciation and amortization | ---- | -12.59%523.47M | ---- | -1.69%598.9M | ---- | 18.31%609.17M | ---- | -2.08%514.89M | ---- | 1.11%525.85M |
| Exchange Loss (gain) | ---- | -62.34%65.22M | ---- | -58.98%173.2M | ---- | 705.88%422.18M | ---- | 257.09%52.39M | ---- | -940.47%-33.35M |
| Special items | ---- | -60.96%-193.38M | ---- | 15.51%-120.14M | ---- | -21.68%-142.19M | ---- | -114.18%-116.86M | ---- | 743.76%824.32M |
| Operating profit before the change of operating capital | ---- | 1.76%25.59B | ---- | 4.27%25.15B | ---- | 4.84%24.12B | ---- | 27.70%23.01B | ---- | 5.16%18.02B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -1,554.53%-272.59M | ---- | 165.94%18.74M | ---- | -87.36%7.05M | ---- | 347.70%55.73M | ---- | -61.99%12.45M |
| Accounts receivable (increase)decrease | ---- | -3.86%-8.33B | ---- | -407.93%-8.02B | ---- | 145.86%2.6B | ---- | -8.36%-5.68B | ---- | 10.04%-5.24B |
| Accounts payable increase (decrease) | ---- | 104.55%137.69M | ---- | -225.19%-3.03B | ---- | 143.53%2.42B | ---- | 211.04%992.7M | ---- | -157.91%-893.96M |
| prepayments (increase)decrease | ---- | -20.41%1.58B | ---- | -0.05%1.99B | ---- | 38.83%1.99B | ---- | -2.05%1.43B | ---- | 110.75%1.46B |
| Special items for working capital changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---38.28M |
| Cash from business operations | -4.65%7.82B | 16.14%18.71B | -9.08%8.2B | -48.25%16.11B | -47.02%9.02B | 57.17%31.14B | 75.84%17.03B | 48.72%19.81B | 139.78%9.69B | -1.90%13.32B |
| Other taxs | -23.33%-1.15B | 7.24%-1.65B | 5.13%-932.26M | -13.42%-1.78B | 0.53%-982.65M | 7.20%-1.57B | 15.31%-987.87M | -61.38%-1.69B | -82.95%-1.17B | 1.51%-1.05B |
| Net cash from operations | -8.24%6.67B | 19.04%17.06B | -9.57%7.27B | -51.53%14.33B | -49.88%8.04B | 63.18%29.57B | 88.31%16.05B | 47.64%18.12B | 150.43%8.52B | -1.93%12.27B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | -73.33%10.38M | ---- | -11.48%38.91M | ---- | 62.75%43.95M | ---- | 14.10%27.01M | ---- | -76.15%23.67M |
| Dividend received - investment | ---- | -38.97%108.59M | ---- | -53.12%177.94M | ---- | 219.01%379.54M | ---- | -71.46%118.98M | ---- | -22.77%416.85M |
| Loan receivable (increase) decrease | ---- | 34.56%2.7M | ---- | -98.42%2.01M | ---- | -64.05%126.99M | ---- | 236.73%353.21M | ---- | -151.69%-258.34M |
| Decrease in deposits (increase) | ---- | ---- | ---- | 200.00%1.81B | ---- | ---1.81B | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | 1,301.00%14.08M | ---- | -94.63%1.01M | ---- | -96.11%18.72M | ---- | 15.65%481.55M | ---- | 1,753.48%416.39M |
| Purchase of fixed assets | 5.90%-12.36B | -12.73%-26.86B | -17.82%-13.13B | -6.05%-23.83B | -71.59%-11.14B | -23.28%-22.47B | 7.68%-6.49B | 9.83%-18.23B | -15.46%-7.03B | -71.50%-20.21B |
| Sale of subsidiaries | ---- | 16,233.10%1.14B | ---- | ---7.05M | ---- | ---- | ---- | -121.73%-10.06M | ---- | --46.29M |
| Acquisition of subsidiaries | ---- | ---374.82M | ---- | ---- | ---- | 1,431.93%3.36B | ---- | 31.87%-252.09M | ---- | ---370M |
| Recovery of cash from investments | 235.52%87.45M | ---- | --26.06M | -96.21%23.56M | ---- | --621.34M | ---- | ---- | 26.92%1.31B | ---- |
| Cash on investment | 90.84%-52.88M | 90.43%-230.66M | 73.39%-577.32M | -486.65%-2.41B | -551.94%-2.17B | 141.54%623.55M | -1,670.34%-332.75M | -3,779.58%-1.5B | ---18.8M | 73.90%-38.69M |
| Other items in the investment business | 969.66%200.44M | 204.62%127.94M | -101.26%-23.05M | --42M | -61.93%1.82B | ---- | 429.86%4.79B | ---- | -6.97%-1.45B | ---- |
| Net cash from investment operations | 11.56%-12.12B | -7.94%-26.07B | -19.27%-13.7B | -26.39%-24.15B | -463.69%-11.49B | -0.52%-19.11B | 71.66%-2.04B | 4.85%-19.01B | -12.11%-7.19B | -85.43%-19.98B |
| Net cash before financing | 15.31%-5.45B | 8.27%-9.01B | -86.52%-6.43B | -193.88%-9.82B | -124.62%-3.45B | 1,275.99%10.46B | 953.76%14.01B | 88.46%-889.39M | 144.13%1.33B | -542.64%-7.71B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -1.42%108.78B | 62.16%247.76B | 35.93%110.35B | -9.93%152.79B | -9.30%81.18B | 43.72%169.62B | 67.70%89.51B | 38.32%118.02B | 94.94%53.37B | 57.20%85.33B |
| Refund | 1.06%-102.6B | -55.18%-230.31B | -35.80%-103.7B | 4.13%-148.42B | 10.55%-76.36B | -36.41%-154.8B | -55.55%-85.37B | -57.00%-113.48B | -154.02%-54.88B | -39.98%-72.28B |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -66.62%2B | ---- | --5.99B |
| Interest paid - financing | -17.09%-1.76B | -0.75%-3.65B | 15.16%-1.5B | 3.97%-3.62B | -1.19%-1.77B | 1.43%-3.77B | 13.16%-1.75B | -18.20%-3.82B | -36.82%-2.02B | 2.09%-3.23B |
| Dividends paid - financing | ---- | -47.09%-2.61B | ---- | -6.46%-1.77B | ---- | -6.71%-1.66B | ---- | -11.59%-1.56B | ---- | -22.87%-1.4B |
| Absorb investment income | ---- | -43.93%596.63M | ---- | 26.06%1.06B | ---- | 43.66%844.08M | ---- | -42.72%587.54M | ---- | 388.69%1.03B |
| Issuance expenses and redemption of securities expenses | ---- | 32.76%-2.06B | ---- | ---3.06B | ---- | ---- | ---- | 60.00%-2B | ---- | ---5B |
| Other items of the financing business | 59.87%-96.8M | -884.38%-2.06B | -3.92%-241.21M | 96.39%-208.95M | 95.78%-232.1M | ---5.78B | -1,683.92%-5.5B | ---- | 364.09%347.37M | ---- |
| Net cash from financing operations | -11.71%4.33B | 290.88%7.35B | 74.11%4.9B | -196.85%-3.85B | 190.39%2.82B | 593.15%3.98B | 2.04%-3.12B | -108.07%-806.51M | -176.32%-3.18B | 687.97%10B |
| Effect of rate | 135.68%9.36M | -728.72%-32.51M | -49.18%-26.23M | 146.48%5.17M | -190.25%-17.59M | -262.28%-11.12M | 501.11%19.49M | -73.89%6.86M | 91.75%-4.86M | 294.68%26.25M |
| Net Cash | 26.85%-1.12B | 87.90%-1.65B | -141.76%-1.53B | -194.70%-13.67B | -105.81%-632.54M | 951.26%14.44B | 688.52%10.89B | -174.00%-1.7B | -260.25%-1.85B | 5,553.88%2.29B |
| Begining period cash | -35.09%3.13B | -73.96%4.81B | -73.72%4.83B | 372.16%18.48B | 369.33%18.37B | -30.15%3.91B | -30.23%3.91B | 92.62%5.6B | 92.83%5.61B | 1.65%2.91B |
| Cash at the end | -38.13%2.02B | -35.05%3.12B | -81.54%3.27B | -73.77%4.81B | 19.49%17.72B | 368.64%18.34B | 295.09%14.83B | -25.13%3.91B | -6.29%3.75B | 79.70%5.23B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | Zhongshen Zhonghuan Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | Tianzhi International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.